Page 9 - Pharmaceutical
European Medicines Agency accepts Mylan-Biocon's insulin glargine application
Glargine is one of the three insulin analogs being co-developed for the global marketplace by Mylan and Biocon - who are partners for a broad portfolio of biosimilars and insulin analogs
 "European Medicines Agency accepts Mylan-Biocon's insulin glargine application")
Sun Pharma buys US-based Ocular Technologies for $ 40 million
The acquisition of Ocular Technologies, which is developing Seciera for the treatment of Dry Eye Disease, will enhance Sun Pharma's specialty ophthalmic pipeline
 "Sun Pharma buys US-based Ocular Technologies for $ 40 million")
Glenmark receives US FDA's nod for antifungal cream
The company has received final approval for nystatin and triamcinolone acetonide cream (100,000 units per gm and 1 mg per gm)
IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals
The CGMP facility will help in extraction, formulation and packaging of medicinal plant based phyto-pharmaceutical drugs
 "IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals")
Large scale imports of APIs from China worries Indian pharma industry
Overwhelming dependence on China for crucial active pharmaceutical ingredients (APIs) and intermediates has emerged as a main worrying area, as per the Assocham-RNCOS study
 "Large scale imports of APIs from China worries Indian pharma industry")
Mylan agrees for $ 465-mn settlement with US DoJ for EpiPen auto-injector
The company has agreed for the payment to resolve questions that have been raised about the classification of EpiPen auto-injector for purposes of the Medicaid Drug Rebate Program
 "Mylan agrees for $ 465-mn settlement with US DoJ for EpiPen auto-injector")
Dr Reddy's Labs forays into Colombia
The company will launch its portfolio of high quality and affordable medicines for cancer patients in the Colombian pharmaceutical market
 "Dr Reddy's Labs forays into Colombia")
Indian biosimilars market to reach $ 40 bn by 2030: Study
With a new regulatory policy and increased affordability offered by biosimilars, the domestic market is expected to grow at an accelerated pace, says a Assocham-Sathguru Management report
 "Indian biosimilars market to reach $ 40 bn by 2030: Study")
Lupin to use MonoSol technology for developing paediatric products
The Mumbai-headquartered will develop multiple paediatric products utilising the US-based MonoSol Rx's proprietary PharmFilm drug delivery technology
 "Lupin to use MonoSol technology for developing paediatric products")
Zydus to market immunosuppressant drug of Switzerland's Neovii in India
The company has inked in-licensing pact with Swiss firm for the launches Grafalon, an immunosuppressant extensively used in solid organ transplants and stem cell transplant
 "Zydus to market immunosuppressant drug of Switzerland's Neovii in India")
Jubilant's lyophilised kit for radiopharmaceuticals receives Australian approval
The company has received TGA's nod for lyophilised kit for the preparation of Technetium 99m Macro-Aggregated Albumin (MAA) injection
Emergent BioSolutions bags $1.6 bn contract for anthrax vaccine in US
The company was awarded the contract by the Biomedical Advanced Research and Development Authority (BARDA) for advanced development & delivery of NuThrax vaccine
 "Emergent BioSolutions bags $1.6 bn contract for anthrax vaccine in US")
AbbVie opens small molecule API facility in Singapore
The facility, which marks AbbVie's first manufacturing presence in Asia, is the first phase of the project to develop a production site in Singapore which will also house a biologics facility
 "AbbVie opens small molecule API facility in Singapore")
US FDA issues thirteen 483 observations for Alkem's Daman facility
Observations were issued to the company following US drug regulator's inspection at its manufacturing facility at Daman from September 20 to September 29, 2016
 "US FDA issues thirteen 483 observations for Alkem's Daman facility")
Non-availability of D-penicillamine disrupts Panacea Biotec's Cilamin capsule supply
The company, which recently released limited quantities of the medicine in the market, is holding talks with Indian and China raw material suppliers to normalise the situation
 "Non-availability of D-penicillamine disrupts Panacea Biotec's Cilamin capsule supply")
Systech eyes growth in Indian pharma sector as traceability gains traction
With developed countries enacting stringent serialisation and tracing regulations, the company aims to capitalise on India's booming pharmaceutical market
 "Systech eyes growth in Indian pharma sector as traceability gains traction")
Kilitch Drugs allotted land in Ethiopia to set up production facility
The company has been looking to expand its presence in Africa with plans to set up manufacturing facilities in Ethiopia and Burkina Faso primarily for nutraceuticals
 "Kilitch Drugs allotted land in Ethiopia to set up production facility")
Suven Life secures patents for CNS drug in India and Japan
These patents are valid through 2026 and 2032 in India and Japan, respectively
Syngene closes deal to buy Strand Life's bioinformatics platforms
The deal to boost Syngene's bioinformatics and data analytics capabilities
 "Syngene closes deal to buy Strand Life's bioinformatics platforms")
Indoco Remedies buys Micro Labs' manufacturing facility in Baddi
The acquired facility, which produces 4.3 billion tablets and 50 million capsules per annum, is close to Indoco's existing manufacturing plant in Baddi
 "Indoco Remedies buys Micro Labs' manufacturing facility in Baddi")
